{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:05:40Z","timestamp":1789135540592,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Psoriasis is a chronic immune-mediated inflammatory disease frequently associated with systemic comorbidities, including an increased prevalence of interstitial lung diseases (ILDs). Progressive fibrosing ILDs are characterized by declining respiratory function and high morbidity, and emerging evidence suggests that type-17 immune pathways may contribute to both psoriatic inflammation and pulmonary fibrosis. Bimekizumab, a monoclonal antibody selectively targeting IL-17A and IL-17F, has demonstrated high efficacy in psoriasis, although its potential impact on fibrotic lung disease remains unclear. We report the case of a 58-year-old man with severe plaque psoriasis and concomitant desquamative interstitial pneumonia (DIP) with features of progressive pulmonary fibrosis. The patient presented with severe restrictive lung disease, reduced diffusing capacity, and exertional desaturation requiring oxygen supplementation. Previous treatments included topical therapies, acitretin, and intermittent systemic corticosteroids, which contributed to worsening skin disease. Bimekizumab was initiated after appropriate screening, resulting in rapid and complete skin clearance by week 12, with no adverse events. Over a 14-month follow-up, a progressive improvement in respiratory function was observed, including increased spirometric parameters, improved diffusing capacity, and enhanced exercise tolerance, with resolution of exertional desaturation and discontinuation of oxygen support during mild activity. No other therapeutic changes were made during this period. Given the role of IL-17 cytokines in inflammation and fibrosis, this observation suggests a potential effect of IL-17A\/F inhibition on fibrotic lung processes. This case highlights a possible dual benefit of bimekizumab in patients with psoriasis and concomitant ILD and supports further investigation into shared pathogenic pathways and targeted therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fmed.2026.1935395","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:06:07Z","timestamp":1789131967000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bimekizumab and progressive pulmonary fibrosis in severe psoriasis: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Alberto","family":"Corr\u00e0","sequence":"first","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Biancamaria","family":"Mariotti","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ruffo di Calabria","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Magnatta","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sanna","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Corti","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Donati","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bonanni","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Daher","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Quintarelli","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Rosi","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit, Careggi University Hospital, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Verdelli","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Caproni","sequence":"additional","affiliation":[{"name":"Rare Dermatological Diseases Unit, Section of Dermatology, Department of Health Sciences, USL Toscana Centro (ERN-SKIN), University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1038\/jid.2012.112","article-title":"Chronic skin-specific inflammation promotes vascular inflammation and thrombosis","volume":"132","author":"Wang","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1365-2133.2008.08749.x","article-title":"Psoriasis and chronic obstructive pulmonary disease: a case-control study","volume":"159","author":"Dreiher","year":"2008","journal-title":"Br J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1468-3083.2011.04009.x","article-title":"Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan","volume":"26","author":"Chiang","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2562311","DOI":"10.1080\/09546634.2025.2562311","article-title":"Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the charlson comorbidity Index","volume":"36","author":"Bernardini","year":"2025","journal-title":"J Dermatolog Treat"},{"key":"B7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.resinv.2023.05.005","article-title":"Pulmonary fibrosis and type-17 immunity","volume":"61","author":"Senoo","year":"2023","journal-title":"Respir Investig"},{"key":"B8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus secukinumab in plaque psoriasis","volume":"385","author":"Reich","year":"2021","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0272-5231(05)70005-8","article-title":"The pathology of smoking-related lung diseases","volume":"21","author":"Aubry","year":"2000","journal-title":"Clin Chest Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2169\/internalmedicine.1802-23","article-title":"Desquamative interstitial pneumonia with progressive pulmonary fibrosis","volume":"63","author":"Utsunomiya","year":"2024","journal-title":"Intern Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"156587","DOI":"10.1016\/j.cyto.2024.156587","article-title":"Dual blockade of interleukin-17A and interleukin-17F as a therapeutic strategy for liver fibrosis: investigating the potential effect and mechanism of brodalumab","volume":"178","author":"Matsuda","year":"2024","journal-title":"Cytokine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/jimmun\/vkaf014","article-title":"Novel ROR\u03b3t inverse agonists limit IL-17-mediated liver inflammation and fibrosis","volume":"214","author":"Dabbaghizadeh","year":"2025","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1470362","DOI":"10.3389\/fcvm.2024.1470362","article-title":"The role of IL-17 family cytokines in cardiac fibrosis","volume":"11","author":"Huang","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cei.13337","article-title":"Interleukin-17 and \u221222 synergy linking inflammation and EMT-dependent fibrosis in sj\u00f6gren\u2019s syndrome","volume":"198","author":"Sisto","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/bjd\/ljae442","article-title":"The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples","volume":"192","author":"Rastrick","year":"2025","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1715474","DOI":"10.3389\/fimmu.2025.1715474","article-title":"Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativa","volume":"16","author":"Ben Abdallah","year":"2026","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/modpathol.2011.166","article-title":"The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis","volume":"25","author":"Nuovo","year":"2012","journal-title":"Mod Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-\u03b21-dependent and -independent mechanisms","volume":"187","author":"Mi","year":"2011","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14799731241291538","DOI":"10.1177\/14799731241291538","article-title":"Smoking-related interstitial lung disease: a narrative review","volume":"21","author":"Casal","year":"2024","journal-title":"Chron Respir Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1935395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:06:08Z","timestamp":1789131968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1935395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":22,"alternative-id":["10.3389\/fmed.2026.1935395"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1935395","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1935395"}}